Effects of Burosumab (KRN23), a Human Monoclonal Antibody to FGF23, in Patients with Tumor-Induced Osteomalacia (TIO) or Epidermal Nevus Syndrome (ENS).

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • De Beur, SJ; Miller, PD; Weber, TJ; Peacock, M; Ruppe, MD; Insogna, K; Luca, D; Theodore-Oklota, C; San Martin, J; Carpenter, T

Published Date

  • December 1, 2017

Published In

Volume / Issue

  • 32 /

Start / End Page

  • S280 - S280

Published By

Pages

  • 1

Electronic International Standard Serial Number (EISSN)

  • 1523-4681

International Standard Serial Number (ISSN)

  • 0884-0431

Conference Name

  • Annual Meeting of the American-Society-for-Bone-and-Mineral-Research (ASBMR)

Conference Location

  • Denver, CO

Conference Start Date

  • September 8, 2017

Conference End Date

  • September 11, 2017